𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity

✍ Scribed by Penelopie Koraka; Bernadette Murgue; Xavier Deparis; Tatty E. Setiati; Catarina Suharti; Eric C.M. van Gorp; C.E. Hack; Albert D.M.E Osterhaus; Jan Groen


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
154 KB
Volume
70
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The kinetics of total and dengue virus‐specific immunoglobulin E (IgE) were studied in serial serum samples obtained from 168 patients, 41 of whom suffered from primary dengue virus infection and 127 suffered from secondary dengue virus infection. Seventy‐one patients were classified as dengue fever, 30 as dengue hemorrhagic fever, and 67 as dengue shock syndrome. A control group included single serum samples from patients with a herpes virus infection (n = 14), non‐dengue febrile patients (n = 10), and healthy blood donors (n = 10). Patients with dengue virus infection had higher levels of total and dengue virus‐specific IgE than non‐dengue patients (P < 0.05). Patients with secondary dengue virus infections had not significantly increased levels of both total and dengue virus‐specific IgE in the acute phase of disease compared to patients with primary dengue virus infections. Dengue virus‐specific IgE was significantly higher in dengue hemorrhagic fever and/or dengue shock syndrome patients compared to dengue fever and non‐dengue patients (P < 0.05). In conclusion, this study showed elevated total and dengue virus‐specific IgE serum antibody levels in the acute stage of disease. Therefore, measurement of both total and dengue virus‐specific IgE serum antibodies can be used as an additional prognostic marker in the development of severe complications in dengue virus infections. In addition, the presence and increase of dengue virus‐specific IgE serum antibodies in patients with dengue virus infections is suggestive of the pathogenetic role that IgE may play in the hemostatic disorders observed in dengue hemorrhagic fever and dengue shock syndrome. J. Med. Virol. 70:91–98, 2003. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Changes in levels of anti-dengue virus I
✍ Soe Thein; Dr. John Aaskov; Thein Thein Myint; Than Nu Shwe; Tin Tin Saw; Aung Z 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

## Abstract Extensive complement activation precedes onset of shock in dengue patients and complement "split products" C3a and C5a could be responsible, directly or indirectly, for the increased vascular permeability and disseminated intravascular coagulation which characterises dengue haemorrhagic

Elevation of soluble VCAM-1 plasma level
✍ Penelopie Koraka; Bernadette Murgue; Xavier Deparis; Eric C.M. van Gorp; Tatty E 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Approximately 1,000 million infections with dengue viruses are estimated to occur annually. The majority of the cases develop mild disease, whereas only small proportion of the infected individuals develop severe hemorrhagic manifestations at the end of the acute phase of illness. In th

Solid-phase radioimmunoassay determinati
✍ Terjo O. Vuorimaa; Pertti P. Arstila; Barry R. Ziola; Aimo A. Salmi; Pentti T. H 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB

The question of the exact disappearance time or possible persistence of measles-specific IgM antibodies after naturally acquired measles virus infections was studied with a sensitive solid-phase radioimmunoassay (RIA) method. A total of 30 patients were analyzed with follow-up times varying from 4.5